The invention relates to compounds of formula pharmaceutical compositions containing the same as well as methods of treating patients suffering from a condition susceptible to amelioration by a Factor Xa inhibitor using the same. The FPGA, access lead network, and plurality of memories are arranged and configured to operate with a variable word width, namely with a word width between 1 and a maximum number of bits. Embodiments may include generating a measure of risk associated with performing the proposed modification to the item description information. A view may be any object capable of being displayed.